CodeBreak200 And Elderly AML Survival
Feb 09, 2023•20 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
CodeBreak200: docetaxel vs. sotorasib in 2nd-line metastatic NSCLC (KRAS-G12C). A new safety signal emerges.
https://doi.org/10.1016/S0140-6736(23)00221-0
A new survival prediction model for elderly patients with AML not receiving intensive therapy.
https://doi.org/10.1002/cncr.34609
For the best experience, listen in Metacast app for iOS or Android